Thiazolidine: A Potent Candidate for Central Nervous System Diseases

Author(s): Radhe S. Bahare, Swastika Ganguly, Ritesh Agrawal, Subodh N. Dikshit

Journal Name: Central Nervous System Agents in Medicinal Chemistry
Formerly Current Medicinal Chemistry - Central Nervous System Agents

Volume 17 , Issue 1 , 2017


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Thiazolidines are multifaceted molecules and exhibit various kinds of biological activities including anticonvulsant and antidepressant activities, chemically thiazolidinediones is a diversified class of heterocyclic nucleus. Thiazolidinediones have shown significant biological activities in various CNS disorder. The mechanism responsible for thiazolidinediones biological activities in CNS based on thiazolidinediones- induced neuroprotection, which is useful in the prevention of microglial activation as well as cytokine expression. The cytokine expression is responsible for inflammatory condition. At the molecular level thiazolidinediones are responsible for the prevention of activation of pro-inflammatory transcription factor as well as promoting the anti-oxidant mechanism in the CNS. In the present article author has elaborated importance of structure activity relationship, molecular mechanism and biological activities with respect to central nervous system. Various investigations suggest that thiazolidinediones may pave the way for the design as well as the discovery of new drug candidates.

Keywords: Thiazolidine, thiazolidinediones, anticonvulsants, antidepressants, neuroprotective.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 1
Year: 2017
Published on: 02 February, 2017
Page: [26 - 29]
Pages: 4
DOI: 10.2174/1871524916666160107110754
Price: $65

Article Metrics

PDF: 34
HTML: 1